Meddevicetracker: medical device intelligence and forecasts

Datamonitor Healthcare, Pink Sheet, Scrip, Medtech Insight, ...

Pharma Intelligence Podcasts

Listen to the Pharma Intelligence podcasts on Spotify, Apple Podcasts, Soundcloud and Alexa

Topic Coronavirus Manufacturing Market Intelligence Clinical Trials Blog Clinical Trials Drug Pricing

Meddevicetracker

Digital Health: Diabetes Apps and Virtual Coaching

Keep your finger on the pulse of digital health technologies with Meddevicetracker’s “Digital Health: Diabetes Apps and Virtual Coaching” report. An extract of this market analysis, covering smartphone apps, continuous glucose monitoring devices, and virtual diabetes coaching, is now available.

Topic Digital Health Diabetes

Biomedtracker, Meddevicetracker

Q4 2019 Outlook Report Extract

What major drug catalysts and events can you expect to see this quarter? Get a view of what's to come with an extract from the full report.

Topic Clinical trials Drug development landscape

Meddevicetracker

Q3 2019 Catalyst Roundup

What were the outcomes of critical catalysts featured in Meddevicetracker’s Q3 2019 Outlook Report? Find out in the Catalyst Roundup: A Review of Select Catalysts from Last Quarter’s Outlook Report. This data-rich graphic is available now – for free.

Topic Drug approval

Meddevicetracker

Meddevicetracker: New Company Portfolio Feature

Meddevicetracker now gives you to the ability to find and follow partners or competitors and track their key activities. Quickly and easily identify new partners and keep tabs on your competition with the portfolio feature in Meddevicetracker.

Topic Business strategies Company analysis

Meddevicetracker

Introducing Meddevicetracker's Market Analysis Tool

Find and manipulate the essential medical devices and diagnostics market intelligence you rely on from Meddevicetracker’s Market Analysis Reports with Meddevicetracker’s new interactive Market Analysis tool. 

Topic Strategy Business strategies Company analysis

Meddevicetracker

MeddeviceTracker Q3 2019 Outlook Report

In this report, we cover catalysts from 27 drugs, devices and diagnostics expected to occur in Q3 2019. For each drug, the likelihood of Phase/PDUFA review success and overall Likelihood of Approval (LOA) given their particular phase, drug class, and disease group are provided.

Topic Strategy Research Drug development landscape Drug review

Meddevicetracker, Biomedtracker

When Part of the Picture Isn't Enough

Staying on top of what’s going in the competitive Medtech market and getting a complete view of the competitive landscape and current market trends is critical to your business. Often, this essential information is fragmented and difficult to find, and gathering and synthesizing it is tedious and time consuming. Now, Biomedtracker puts this critical information at your fingertips, saving you time and effort. The new “Associated Products” section on relevant Biomedtracker Drug Profile pages shows you the full competitive landscape – including drugs, devices, and diagnostics – with a single search.

Topic Business strategies Medtech